Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Seiden

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|January 11, 2007
Drug evaluation: tesetaxel--an oral semisynthetic taxane derivativeMaria Roche, Helena Kyriakou, Michael Seiden
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
BMS-247550 Bristol-Myers Squibb/GBFNancy Lin, Katherine Brakora, Michael Seiden
Diagnostics (Basel, Switzerland)|May 28, 2022
The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. <i>Diagnostics</i> 2021, <i>11</i>, 2171Eric A Klein, Tomasz M Beer, Michael Seiden
The American Journal of Medicine|February 16, 2023
The Promise of Multicancer Early DetectionEric A Klein, Tomasz M Beer, Michael Seiden
Clinical Chemistry and Laboratory Medicine|February 4, 2022
Multicancer early detectionEric A Klein, Tomasz M Beer, Michael Seiden
JCO Precision Oncology|March 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisCharles Swanton, Alan Bryce, Allen L Cohn, et al.
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Plos One|April 12, 2011
Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancerPanagiotis A Konstantinopoulos, Stephen A Cannistra, Helen Fountzilas, et al.
Population Health Management|August 29, 2020
A Simple Algorithm for Return to Workplace Employer Antibody TestingWilliam H Shrank, Brian Caveney, Steve Miller, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|January 11, 2007
Drug evaluation: tesetaxel--an oral semisynthetic taxane derivativeMaria Roche, Helena Kyriakou, Michael Seiden
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
BMS-247550 Bristol-Myers Squibb/GBFNancy Lin, Katherine Brakora, Michael Seiden
Diagnostics (Basel, Switzerland)|May 28, 2022
The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. <i>Diagnostics</i> 2021, <i>11</i>, 2171Eric A Klein, Tomasz M Beer, Michael Seiden
The American Journal of Medicine|February 16, 2023
The Promise of Multicancer Early DetectionEric A Klein, Tomasz M Beer, Michael Seiden
Clinical Chemistry and Laboratory Medicine|February 4, 2022
Multicancer early detectionEric A Klein, Tomasz M Beer, Michael Seiden
JCO Precision Oncology|March 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisCharles Swanton, Alan Bryce, Allen L Cohn, et al.
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Plos One|April 12, 2011
Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancerPanagiotis A Konstantinopoulos, Stephen A Cannistra, Helen Fountzilas, et al.
Population Health Management|August 29, 2020
A Simple Algorithm for Return to Workplace Employer Antibody TestingWilliam H Shrank, Brian Caveney, Steve Miller, et al.
Pageof 1